CTSG and autoimmune myocarditis: For example, linagliptin has been reported to effectively inhibit myocardial inflammation by increasing serpina3n activity and repressing cathepsin G activity in mice with experimental autoimmune myocarditis [22], suggesting that serpina3n exerts an anti-inflammatory role.